Form 4: DexCom Director Bridgette Heller Receives RSU Grant

DexCom, Inc. director Bridgette P. Heller was granted 5,575 restricted stock units as part of an equity compensation award.

Summary

• Director Bridgette P. Heller acquired 5,575 restricted stock units (RSUs) of DexCom, Inc. common stock.
• The transaction occurred on May 28, 2026, at a price of $0 per share as part of an equity grant.
• Following this transaction, the director's total beneficial ownership of common stock increased to 30,582 shares.
• The RSUs are scheduled to vest on the earlier of the one-year anniversary of the grant date or the 2027 Annual Meeting of Stockholders.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries a neutral sentiment.

Positives

• Director equity alignment with shareholder interests through the receipt of stock-based compensation.

Negatives

• None identified.

Risks

• Standard market risks associated with equity ownership and potential volatility in DexCom, Inc. share price.

Future Outlook

The RSUs will vest in full on the earlier of May 28, 2027, or the date of the 2027 Annual Meeting of Stockholders.

Industry Context

StockSavvy.ai notes that director equity grants are standard corporate governance practices designed to align board member incentives with long-term shareholder value in the medical device and continuous glucose monitoring sector.

Comparison to Industry Standards

• The grant of RSUs to non-employee directors is consistent with standard compensation practices for S&P 500 and mid-cap healthcare companies.
• Vesting schedules tied to annual meetings are a common industry benchmark for director equity awards.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation event for a board member.

Next Steps

• Vesting of the 5,575 RSUs on the earlier of May 28, 2027, or the 2027 Annual Meeting of Stockholders.

Key Dates

Keywords

DexCom, DXCM, Form 4, Insider Trading, Equity Compensation, Director Compensation